Response of patients with advanced neoplasms to the intravenous administration of alpha-peltatin.
D061605:Administration, Intravenous; D009369:Neoplasms / Q000628:therapy*; D011033:Podophyllin; D011034:Podophyllotoxin / Q000031:analogs & derivatives
C049798:alpha-peltatin; D011033:Podophyllin; D011034:Podophyllotoxin
NEOPLASMS/therapy; PODOPHYLLIN